Recently, Zhengzhou Jinbaihe Biological Engineering Co., Ltd. (short name JBH Bio) has proposed to apply for listing of its stock on the National Equities Exchange and Quotations for public transfer and has engaged ZhongYin to represent it exclusively on NEEQ listing. The team led by our senior partner Wu Zetao will serve as presenting attorneys in this project.

JBH Bio is one of the earliest professional researchers & developers and producers of functional probiotics in China; its main business involves micro-ecological medicine & health care, ecological planting, green breeding, eco-environmental protection and other industries; its leading products and services include “Baihe” branded probiotic health food (“Qixiao” probiotic capsule series and “Qixiao” probiotic particle series), “Baihe” branded probiotic functional foods (infant probiotics series, children probiotics series, middle-aged probiotics series, female probiotics series, probiotics + series, and prebiotics series), “Jinmengda” branded ecological planting micro-fertilizer series, “Baihe” branded micro-ecological feed additive series, “Baihe” branded microbial environmental protection product series, and so on.

The team of Wu Zetao has extensive experience in practicing in the capital markets and may deliver distinctive outcome in dispute resolution involving the capital market. Later, throughout the NEEQ listing, it will provide the client with professional legal services including but not limited to due diligence, standardization and rectification, and issuance of legal documents.